BioCentury
ARTICLE | Clinical News

Aztec controlled-release formulation of AZT: Started Phase III comparison trials

November 8, 1993 8:00 AM UTC

Verex Laboratories Inc. (VRXL) Product: Aztec controlled-release formulation of AZT Indication: HIV infection Status: Started Phase III comparison trials against Retrovir AZT in 200 patients ...